JeeSuk Chang/X
Feb 24, 2025, 14:08
JeeSuk Chang: The 2nd analysis of SABR-5
JeeSuk Chang, Radiation Oncologist at Yonsei Cancer Center, shared an article by Sarah Baker, et al. on X:
“Check out the 2nd analysis of SABR-5!
Honored to be part of this team.
Ultracentral tumors = distant/widespread mets PFS/OS (despite similar LC).
Re-emphasizing the importance of risk-adapted dosing and strict OAR constraints.”
The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 Trial.
Authors: Sarah Baker, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 19:09
Apr 1, 2025, 18:48
Apr 1, 2025, 18:37
Apr 1, 2025, 18:26
Apr 1, 2025, 18:22